These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 9211570

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of moclobemide in endogenous depression: a survey of recent data.
    Woggon B.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
    [Abstract] [Full Text] [Related]

  • 26. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [Abstract] [Full Text] [Related]

  • 27. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():43. PubMed ID: 2248067
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression.
    Paykel ES.
    Acta Psychiatr Scand Suppl; 1995 Jan; 386():22-7. PubMed ID: 7717091
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
    Laux G, Beckmann H, Classen W, Becker T.
    J Neural Transm Suppl; 1989 Jan; 28():45-52. PubMed ID: 2677241
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ, Moritz E, Hellstern K, Malanowski H.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():46-7. PubMed ID: 2248069
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
    Ebert D, Demling J.
    Pharmacopsychiatry; 1991 Nov; 24(6):229-31. PubMed ID: 1687486
    [Abstract] [Full Text] [Related]

  • 38. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

  • 39. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
    Casacchia M, Carolei A, Barba C, Frontoni M, Rossi A, Meco G, Zylberman MR.
    Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.